Results
1
-
10
of
110
<
1
2
3
...
10
11
>
Greig SL.
Sofosbuvir/Velpatasvir: A Review in Chronic Hepatitis C.
,
Drugs
[DOI: 10.1007/s40265-016-0648-2]
Johnston EV; Bog?r K; B?ckvall JE.
Enantioselective synthesis of (R)-bufuralol via dynamic kinetic resolution in the key step.
,
The Journal of organic chemistry
[DOI: 10.1021/jo100936f]
Midorikawa K; Uchida T; Okamoto Y; Toda C; Sakai Y; Ueda K; Hiraku Y; Murata M; Kawanishi S; Kojima N.
Metabolic activation of carcinogenic ethylbenzene leads to oxidative DNA damage.
,
Chemico-biological interactions
[DOI: 10.1016/j.cbi.2004.09.020]
German P; Mathias A; Brainard D; Kearney BP.
Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C.
,
Clinical pharmacokinetics
[DOI: 10.1007/s40262-016-0397-0]
Thokala P; Simpson EL; Tappenden P; Stevens JW; Dickinson K; Ryder S; Harrison P.
Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective.
,
PharmacoEconomics
[DOI: 10.1007/s40273-016-0387-y]
Keating GM.
Sofosbuvir: a review of its use in patients with chronic hepatitis C.
,
Drugs
[DOI: 10.1007/s40265-014-0247-z]
Keating GM; Vaidya A.
Sofosbuvir: first global approval.
,
Drugs
[DOI: 10.1007/s40265-014-0179-7]
Elfiky AA; Elshemey WM; Gawad WA; Desoky OS.
Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes.
,
The protein journal
[DOI: 10.1007/s10930-013-9462-9]
Poordad F; Chee GM.
Interferon free hepatitis C treatment regimens: the beginning of another era.
,
Current gastroenterology reports
[DOI: 10.1007/s11894-011-0229-1]
Synthetic Routes to Sofosbuvir
,
Synthesis of Heterocycles in Contemporary Medicinal Chemistry
[DOI: 10.1007/7081_2015_183]
<
1
2
3
...
10
11
>